NCT02628067 2025-09-22KEYNOTE 158Merck Sharp & Dohme LLCPhase 2 Active not recruiting1,609 enrolled 5 FDA
NCT00986661 2022-11-02A Study to Assess PV-10 Chemoablation of Cancer of the LiverProvectus PharmaceuticalsPhase 1 Unknown78 enrolled
NCT01327612 2021-02-21Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)AmgenPhase 2 Completed12 enrolled 21 charts
NCT01271959 2012-10-05A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry StudyPrecision TherapeuticsTerminated167 enrolled